The 1996 report of a World Health Organization expert committee on hypertension control
- PMID: 8884546
The 1996 report of a World Health Organization expert committee on hypertension control
Comment in
-
A critique of the 1996 World Health Organisation expert committee report on hypertension.J Hypertens. 1997 Jun;15(6):683-5. doi: 10.1097/00004872-199715060-00015. J Hypertens. 1997. PMID: 9218189 No abstract available.
Similar articles
-
Moderately elevated blood pressure. A report from SBU, the Swedish Council on Technology Assessment in Health Care.J Intern Med Suppl. 1995;737:1-225. J Intern Med Suppl. 1995. PMID: 9043531 Review. No abstract available.
-
[Primary prevention of essential hypertension. Report of the Expert Committee of the World Health Organization. I].Przegl Lek. 1985;42(6):500-6. Przegl Lek. 1985. PMID: 4070656 Polish. No abstract available.
-
[Primary prevention of idiopathic hypertension. Report of the World Health Organization Expert Committee. II].Przegl Lek. 1985;42(10):685-94. Przegl Lek. 1985. PMID: 4089208 Polish. No abstract available.
-
[Consensus on control of arterial hypertension in Spain. Ministry of Health and Consumption].Rev Esp Cardiol. 1991 Feb;44(2):76-94. Rev Esp Cardiol. 1991. PMID: 1906191 Review. Spanish. No abstract available.
-
[Prevention of ischemic heart disease. Report of the World Health Organization (WHO) Expert Committee. IV].Przegl Lek. 1984;41(5):385-94. Przegl Lek. 1984. PMID: 6473816 Polish. No abstract available.
Cited by
-
Does being under treatment improve knowledge attitude practice for hypertension: A hospital-based study from North India.J Family Med Prim Care. 2017 Apr-Jun;6(2):279-283. doi: 10.4103/2249-4863.220040. J Family Med Prim Care. 2017. PMID: 29302532 Free PMC article.
-
Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension.Drugs. 1997 Dec;54(6):885-902. doi: 10.2165/00003495-199754060-00007. Drugs. 1997. PMID: 9421695 Review.
-
Antihypertensive prescribing practices: impact of the antihypertensive and lipid-lowering treatment to prevent heart attack trial.J Clin Hypertens (Greenwich). 2006 Dec;8(12):860-4. doi: 10.1111/j.1524-6175.2006.05781.x. J Clin Hypertens (Greenwich). 2006. PMID: 17170611 Free PMC article.
-
Candesartan cilexetil. A review of its use in essential hypertension.Drugs. 1998 Nov;56(5):847-69. doi: 10.2165/00003495-199856050-00013. Drugs. 1998. PMID: 9829158 Review.
-
Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: a pharmacoeconomic comparison of antihypertensive efficacy of beta blockers.Indian J Pharmacol. 2014 Sep-Oct;46(5):485-9. doi: 10.4103/0253-7613.140577. Indian J Pharmacol. 2014. PMID: 25298575 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical